Zentalis Pharmaceuticals, Inc. (ZNTL) - Stock Prices, Stock Peers & Analysis

Home
ZNTL

Company Name	Zentalis Pharmaceuticals, Inc.
Symbol	ZNTL
Currency	USD
Price	4.36
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	310,030,880
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	2.83 - 22.7
Industry	Biotechnology
Sector	Healthcare
CEO	Dr. Kimberly Lynn Blackwell M.D.
Website	https://zentalis.com

An error occurred while fetching data.

About Zentalis Pharmaceuticals, Inc.

Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid tumors;